ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $252,000 | -19.2% | 4,232 | -1.4% | 0.04% | -2.6% |
Q1 2022 | $312,000 | -5.2% | 4,290 | +9.7% | 0.04% | -2.5% |
Q4 2021 | $329,000 | +3.5% | 3,909 | +11.0% | 0.04% | -4.8% |
Q3 2021 | $318,000 | +0.6% | 3,521 | +6.1% | 0.04% | -2.3% |
Q2 2021 | $316,000 | +0.3% | 3,318 | +19.9% | 0.04% | -8.5% |
Q1 2021 | $315,000 | – | 2,768 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |